• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与帕金森病相关的睡眠障碍。

Sleep disorder related to Parkinson's disease.

作者信息

Partinen M

机构信息

Haaga Centre for Neurological Research, Helsinki, Finland.

出版信息

J Neurol. 1997 Apr;244(4 Suppl 1):S3-6. doi: 10.1007/BF03160564.

DOI:10.1007/BF03160564
PMID:9112582
Abstract

Sleep disorders occur in 74-98% of patients with idiopathic Parkinson's disease (PD), adversely affecting their quality of life. Sleep disruption takes the form of sleep fragmentation with frequent and prolonged awakenings and daytime sleepiness. Nocturia, difficulty in turning over in bed, painful leg cramps, vivid dreams/nightmares, back pain, limb/facial dystonia and leg jerks are the main causes of nocturnal awakening in PD patients. Sleep disturbance gradually worsens with disease progression, suggesting that it is related to the severity of the disease. Sleep disturbances may be generally considered as part of the normal aging process, being more common in the elderly. However, no significant associations between sleep disturbances and either age or disease duration was found in a survey of 100 PD patients. Disturbed sleep maintenance in PD patients was more severe than in age-matched controls, and nocturnal awakening was frequently caused by nocturia, pain, stiffness and difficulty in turning over in bed. Sleep disturbance is also a complication of chronic levodopa therapy. Recent data suggest that controlled-release levodopa is less likely to cause nocturnal symptoms than standard levodopa, particularly in mild-to-moderate disease. Depression, which is common in PD patients, contributes to sleep disturbance but has a lesser influence than the disease process itself. Hypnotic and sedative agents, as well as anti-depressants if required, are useful in ameliorating sleep disturbances in PD patients; intranasal desmopressin appears to be effective in reducing nocturia.

摘要

睡眠障碍发生在74%至98%的特发性帕金森病(PD)患者中,对他们的生活质量产生不利影响。睡眠中断表现为睡眠碎片化,频繁且长时间觉醒以及白天嗜睡。夜尿症、在床上翻身困难、腿部疼痛性痉挛、生动的梦境/噩梦、背痛、肢体/面部肌张力障碍和腿部抽搐是PD患者夜间觉醒的主要原因。睡眠障碍随着疾病进展逐渐恶化,表明它与疾病严重程度相关。睡眠障碍通常可能被视为正常衰老过程的一部分,在老年人中更为常见。然而,在一项对100名PD患者的调查中,未发现睡眠障碍与年龄或病程之间存在显著关联。PD患者的睡眠维持障碍比年龄匹配的对照组更严重,夜间觉醒频繁由夜尿症、疼痛、僵硬和在床上翻身困难引起。睡眠障碍也是慢性左旋多巴治疗的一种并发症。最近的数据表明,控释左旋多巴比标准左旋多巴更不容易引起夜间症状,特别是在轻度至中度疾病中。抑郁症在PD患者中很常见,会导致睡眠障碍,但影响小于疾病本身。催眠药和镇静剂,以及必要时的抗抑郁药,对改善PD患者的睡眠障碍有用;鼻内去氨加压素似乎对减少夜尿症有效。

相似文献

1
Sleep disorder related to Parkinson's disease.与帕金森病相关的睡眠障碍。
J Neurol. 1997 Apr;244(4 Suppl 1):S3-6. doi: 10.1007/BF03160564.
2
Detection and management of sleep disturbances in Parkinson's disease.帕金森病睡眠障碍的检测与管理
Nihon Rinsho. 2017 Jan;75(1):125-135.
3
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease.帕金森病夜间睡眠障碍及日间过度嗜睡的治疗
Neurology. 2004 Oct 26;63(8 Suppl 3):S35-8. doi: 10.1212/wnl.63.8_suppl_3.s35.
4
Sleep disorders in Parkinson's disease.帕金森病中的睡眠障碍
J Neurol. 1998 May;245 Suppl 1:S15-8. doi: 10.1007/pl00007731.
5
Sleep and impulsivity in Parkinson's disease.帕金森病的睡眠与冲动。
Parkinsonism Relat Disord. 2013 Nov;19(11):991-4. doi: 10.1016/j.parkreldis.2013.06.018. Epub 2013 Jul 21.
6
Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.帕金森病伴睡眠障碍患者的脑磁共振成像形态学分析
BMC Neurol. 2018 Jun 20;18(1):88. doi: 10.1186/s12883-018-1092-6.
7
Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability.实现帕金森病症状的24小时控制:运用客观指标改善夜间功能障碍
Eur Neurol. 2001;46 Suppl 1:3-10. doi: 10.1159/000058047.
8
Sleep-wake disturbances in Parkinson's disease: current evidence regarding diagnostic and therapeutic decisions.帕金森病的睡眠-觉醒障碍:关于诊断和治疗决策的当前证据。
Eur Neurol. 2012;67(5):257-67. doi: 10.1159/000335078. Epub 2012 Mar 30.
9
Dopamine agonists and sleep in Parkinson's disease.多巴胺激动剂与帕金森病中的睡眠
Neurology. 2002 Feb 26;58(4 Suppl 1):S71-8. doi: 10.1212/wnl.58.suppl_1.s71.
10
Sleep disturbances in Parkinson's disease.帕金森病的睡眠障碍。
Mov Disord. 2010;25 Suppl 1(Suppl 1):S117-22. doi: 10.1002/mds.22788.

引用本文的文献

1
Neuropsychopharmacological Induction of (Lucid) Dreams: A Narrative Review.神经心理药理学诱导(清醒)梦:一项叙述性综述。
Brain Sci. 2024 Apr 25;14(5):426. doi: 10.3390/brainsci14050426.
2
Sleep in Hospitalized Patients.住院患者的睡眠
Clocks Sleep. 2019 Feb 25;1(1):151-165. doi: 10.3390/clockssleep1010014. eCollection 2019 Mar.
3
Gut Inflammation in Association With Pathogenesis of Parkinson's Disease.与帕金森病发病机制相关的肠道炎症

本文引用的文献

1
Sleep in Parkinson's disease.帕金森病中的睡眠问题
Acta Neurol Scand. 1993 Mar;87(3):167-70. doi: 10.1111/j.1600-0404.1993.tb04095.x.
2
Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease.帕金森病中的睡眠、日间过度嗜睡和疲劳
J Neural Transm Park Dis Dement Sect. 1993;5(3):235-44. doi: 10.1007/BF02257678.
3
Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring.帕金森病中的睡眠障碍。通过持续活动监测进行评估。
Front Mol Neurosci. 2019 Sep 13;12:218. doi: 10.3389/fnmol.2019.00218. eCollection 2019.
4
Enabling breakthroughs in Parkinson's disease with wearable technologies and big data analytics.借助可穿戴技术和大数据分析实现帕金森病研究的突破。
Mhealth. 2016 May 12;2:20. doi: 10.21037/mhealth.2016.04.02. eCollection 2016.
5
Sleep Disorders as a Risk to Language Learning and Use.睡眠障碍对语言学习与使用构成风险。
EBP Briefs. 2015 May;10(1):1-21.
6
Associations of sleep disturbance symptoms with health-related quality of life in Parkinson's disease.帕金森病睡眠障碍症状与健康相关生活质量的相关性。
J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):319-26. doi: 10.1176/appi.neuropsych.12070175.
7
Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's disease.神经退行性疾病中的睡眠和昼夜节律功能障碍:来自亨廷顿舞蹈症小鼠模型的见解
Minerva Pneumol. 2012 Sep;51(3):93-106.
8
Parkinson's disease patients' subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life.帕金森病患者对慢性疼痛、睡眠模式和健康相关生活质量特征的主观描述。
Neuropsychiatr Dis Treat. 2012;8:435-42. doi: 10.2147/NDT.S34882. Epub 2012 Oct 12.
9
Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.亚慢性经口给予神经毒素 1-三氯甲基-1,2,3,4-四氢-β-咔啉后大鼠夜间活动的改变。
J Neural Transm (Vienna). 2009 Oct;116(10):1267-71. doi: 10.1007/s00702-009-0261-6. Epub 2009 Jul 16.
10
Use of sleep-promoting medications in nursing home residents : risks versus benefits.疗养院居民使用助眠药物:风险与益处
Drugs Aging. 2006;23(4):271-87. doi: 10.2165/00002512-200623040-00001.
Arch Neurol. 1994 Sep;51(9):922-8. doi: 10.1001/archneur.1994.00540210094018.
4
Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease.鼻内去氨加压素对帕金森病夜间多尿的有益作用。
Mov Disord. 1995 May;10(3):337-40. doi: 10.1002/mds.870100318.
5
Sleep in Parkinson's disease. The role of depression and anxiety.帕金森病中的睡眠。抑郁和焦虑的作用。
Psychosomatics. 1995 May-Jun;36(3):262-6. doi: 10.1016/S0033-3182(95)71665-6.
6
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.慢性左旋多巴治疗过程中的睡眠中断:左旋多巴所致精神病的早期特征。
Clin Neuropharmacol. 1982;5(2):183-94. doi: 10.1097/00002826-198205020-00003.
7
Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF.发作性睡病与特发性嗜睡症:脑脊液中的生物胺及相关化合物
Neurology. 1982 Nov;32(11):1299-302. doi: 10.1212/wnl.32.11.1299.
8
A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease.左旋多巴缓释制剂(美多芭HBS)治疗帕金森病的夜间及清晨功能障碍
Eur Neurol. 1987;27 Suppl 1:126-34. doi: 10.1159/000116207.
9
Madopar HBS in Parkinson patients with nocturnal akinesia.左旋多巴/苄丝肼控释片用于治疗伴有夜间运动不能的帕金森病患者。
Clin Neurol Neurosurg. 1988;90(1):35-9. doi: 10.1016/s0303-8467(88)80007-6.
10
The nighttime problems of Parkinson's disease.帕金森病的夜间问题。
Clin Neuropharmacol. 1988 Dec;11(6):512-9. doi: 10.1097/00002826-198812000-00004.